Once-Weekly Albiglutide in the Management of Type 2 Diabetes: Patient Considerations

Patient Preference and Adherence - New Zealand
doi 10.2147/ppa.s53075
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Patient Preference for Once-Weekly Dosing in Type 2 Diabetes Mellitus in Japan

Journal of Health Economics and Outcomes Research
2016English

Dulaglutide: Third Once-Weekly GLP-1 Agonist for Type 2 Diabetes

Pharmacy Today
2014English

Exenatide Extended-Release: A Once Weekly Treatment for Patients With Type 2 Diabetes

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2014English

Exenatide Once-Weekly Injection for the Treatment of Type 2 Diabetes in Chinese Patients: Current Perspectives

Therapeutics and Clinical Risk Management
2015English

Adherence to GLP-1 Receptor Agonist Therapy Administered by Once-Daily or Once-Weekly Injection in Patients With Type 2 Diabetes in Germany

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2016English

Myocardial Considerations in Type 2 Diabetes: 2018

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2018English

Management of a Patient at High Risk of Type 2 Diabetes

London Journal of Primary Care
EnvironmentalPublic HealthOccupational Health
2016English

Management of Type 2 Diabetes

English

Pdb87 - A Cost-Of-Control Analysis: Once-Weekly Semaglutide Reduces Cost of Reaching Treatment Targets in Patients With Type 2 Diabetes Mellitus in Norway

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy